Kangmei Healthcare Cloud Service Co to Launch Cancer Therapy Management Services

Friday, June 3, 2016 Cancer News J E 4
Cloud EHR-Based Bi-lingual Service Platform for Chinese-Speaking Cancer Patients Announced at 2016 ASCO Annual Meeting

CHICAGO, June 3, 2016 /PRNewswire/ -- Kangmei Healthcare Cloud Service Co., Ltd today announced the addition of cancer therapy management services to its existing products in senior care services and smart healthcare delivery at 2016 ASCO Annual Meeting in Chicago.

John Peng, General Manager and President of Kangmei Healthcare Cloud Service Co., commented, "Every year, more than 4 million new cancer patients are diagnosed in China, and around 60% of these new patients are over 60 years old.  Moving into cancer services is a natural extension of our services.  Through internet and mobile deployed tools, we help to allocate scarce quality medical resources, and to facilitate communication between doctors and patients." Mr. Peng led Microsoft Cloud Services in Greater China and directed Microsoft global on-line services. He was also responsible for Microsoft HealthVault services.

Kangmei Healthcare Cloud has built its core capabilities around providing integrated solutions for the healthcare and senior services industry.  The company's cloud-based platforms let doctors manage their patients more efficiently and reach into more communities. The mobile tools empower the patients to seek care and advices from experts around the globe.  Cloud based data analyses enables virtual care coordination and chronic disease management.

Kangmei Healthcare Cloud's cancer therapy management platform provides expert-curated knowledge base on cancer treatments in Chinese to enlighten and empower patients. These patients can easily update their records and side-effects through smart phones.  The structured records are stored securely and monitored by dedicated case management teams. A doctor would have access to the full medical history of a patient and tailor the treatment plan based on advices provided through systemic analysis of the patient's clinical and genomic profile.  Cancer patients would make more educated decisions, and stay compliant during their treatments. 

Dr. Tingting Zhang, Ph.D., Vice President leading cancer therapy management services at Kangmei Healthcare Cloud, added, "Our services are not limited by geographic borders and time zones.  We aim to bridge the gaps faced by Chinese speaking cancer patients worldwide.  A patient in mainland China can opt to seek consultation from a pathologist in Taiwan, and a client in New Zealand may book an in-person appointment with an experience oncologist in another country within a week.  We have signed up top cancer doctors in mainland China, Taiwan, and the United States. We are now looking for collaborators to bring our services to more patients." Dr. Zhang, an oncology and immunology expert specialized in translational and personalized medicine, joined the company in June 2015.  She held analytical positions at Eli Lilly and Roche before moving into personalized healthcare and global healthcare delivery.

About Kangmei Healthcare Cloud Service Co

Kangmei Healthcare Cloud Service Co., Ltd is a company focused on delivering and coordinating healthcare through internet, mobile, and wearable technologies. It is a subsidiary of Kangmei Pharmaceutical Co., Ltd (SHA: 600518) which is primarily engaged in the manufacture and sale of pharmaceutical products including Chinese herbal medicine and chemical drugs, as well as medical devices.


To view the original version on PR Newswire, visit:

SOURCE Kangmei Healthcare Cloud Service



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Clean Slate Tattoo Removal Upgrades To The Latest ...
ADI-PEG 20 plus Gemcitabine and nab-Paclitaxel Sho...